Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
March 13 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality development and
manufacturing services to biotechnology and pharmaceutical
companies, today announced that the company will participate at two
upcoming CDMO industry conferences. These include KNect365
Life Sciences’ BioProcess International West 2018, being held March
19-22, 2018 in San Francisco, CA, and DCAT Week 2018, being held
March 19-22, 2018 in New York, NY.
Details of these activities are as follows:
KNect365 Life Sciences' BioProcess International West:
Avid will host corporate booth #415 showcasing
the company’s comprehensive range of process development, high
quality cGMP clinical and commercial manufacturing services.
Company representatives will provide a virtual tour of Avid’s
40,000 square foot state-of-the-art commercial biomanufacturing
suite (Myford facility). The Myford facility is designed with
cutting-edge, single-use equipment to accommodate a fully
disposable biomanufacturing process. A wide range of
innovative features are incorporated into the facility including
monolithic modular clean rooms, dedicated support utilities for
each key processing area, and the industry’s most advanced
single-use production systems and flexible solutions.
Uni-directional process flows separate personnel and materials and
provide assurance that the design meets the most stringent
regulatory requirements for commercial biologics API
manufacturing.
DCAT Week:
Avid representatives will also be onsite at DCAT
Week, an event hosted by the Drug, Chemical & Associated
Technologies Association (DCAT). In addition to participating
in related networking events, the company is hosting a table at the
DCAT Annual Dinner on Thursday, March 22.
For additional details on these events, please visit:
https://lifesciences.knect365.com/bpi-west/ and
https://dcatweek.org/.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive
range of process development, high quality cGMP clinical and
commercial manufacturing services for the biotechnology and
biopharmaceutical industries. With nearly 25 years of
experience producing monoclonal antibodies and recombinant proteins
in batch, fed-batch and perfusion modes, Avid's services include
cGMP clinical and commercial product manufacturing, purification,
bulk packaging, stability testing and regulatory strategy,
submission and support. The company also provides a variety
of process development activities, including cell line development
and optimization, cell culture and feed optimization, analytical
methods development and product characterization.
www.avidbio.com
Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc.
(800) 987-8256
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2023 to Apr 2024